The endTB trial results will be presented, for the first time, at the Union World Conference on Lung Health, in Paris, France, on November 15-18.
You can find the details about the accepted sessions below. Join us at the conference!
Symposium title: Innovation to guide practice in MDR/RR-TB treatment: efficacy and safety results of the endTB trial
Date: November 15
Session code: SP01
The endTB results will also be discussed in the Community Connect space:
Session title: Researchers sharing with communities: Results from the endTB trial
Date: November 17
Room: Foyer Bleu Paris
Session code: CC-20
More details on the conference programme and registration here: https://conf2023.theunion.org/.
The endTB results will inform the development of project proposals to be submitted to Unitaid’s recently released call for proposals.
We welcome any request for information or support from applicants after the results presentation in mid-November; please contact us via : [email protected].
endTB-Q results will be made public in early 2025. Proposals could already anticipate additional work packages to support introduction depending on results.